abstract |
The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2 , X, Ring A, Ring B and Ring C have any of the meanings hereinbefore defined in the description; process for their preparation; pharmaceutical compositions containing them and their use in treating MCT4 mediated diseases. |